Effects of micronized purified flavonoid fraction (Daflon) on pelvic pain in women with laparoscopically diagnosed pelvic congestion syndrome: a randomized crossover trial.
This randomized crossover trial found that micronized purified flavonoid fraction (Daflon) significantly reduced the frequency and severity of pelvic pain in women diagnosed with pelvic congestion syndrome.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (7)
- Pelvic vein incompetence: clinical perspectives 2017
- Non-surgical interventions for the management of chronic pelvic pain 2014
- Pelvic congestion syndrome 2013
- Complementary and Alternative Treatments for Chronic Pelvic Pain 2013
- Pelvic Congestion Syndrome-Associated Pelvic Pain: A Systematic Review of Diagnosis and Management 2010
- The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study 2009
- Pelvic Congestion Syndrome 2008
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:14:54.534439+00:00